Skip to main navigation Skip to search Skip to main content

Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma

  • Andrzej J. Jakubowiak
  • , Tara Kendall
  • , Ammar Al-Zoubi
  • , Yasser Khaled
  • , Shin Mineishi
  • , Asra Ahmed
  • , Erica Campagnaro
  • , Christine Brozo
  • , Thomas Braun
  • , Moshe Talpaz
  • , Mark S. Kaminski

Research output: Contribution to journal › Article › peer-review

69   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Neuroscience

Immunology and Microbiology